DaVita Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Javier J. Rodriguez
- Full Time Employees
- 78,000
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 2000 16th Street Denver CO United States 80202
- IPO Date
- Oct 31, 1995
- CIK
- 0000927066
- Website
- davita.com
- Similar Companies
- Business
- DaVita Inc. DaVita Inc. provides kidney care services, primarily dialysis treatments for patients with chronic kidney failure and end-stage kidney disease; operates approximately 2,675 outpatient dialysis centers in the United States serving more than 200,000 patients and 367 centers in 11 other countries serving around 49,400 patients; offers related laboratory services, including routine tests for dialysis patients and other physician-prescribed tests; delivers home-based hemodialysis, hospital inpatient dialysis, and acute inpatient dialysis services; provides integrated kidney care and disease management through DaVita Integrated Kidney Care for risk-based arrangements; conducts clinical research via DaVita Clinical Research since 1985 across pharmaceutical and medical device development; supports nephrologists with technology solutions through DaVita Physician Solutions; and develops innovative health care solutions for kidney disease patients through DaVita Venture Group. The company, incorporated in 1994 and formerly known as DaVita HealthCare Partners Inc. until a 2016 name change, maintains world headquarters in Denver, Colorado, and generates the majority of revenues from Medicare and government-based programs while targeting commercial payers for higher margins; it holds a 37% share of the U.S. dialysis market and operates internationally across regions including Latin America, Europe, and Asia. DaVita Inc. recently expanded internationally through 2024 acquisitions from Fresenius Medical Care for $300 million, adding over 270 clinics in Brazil, Colombia, Chile, and Ecuador to become Latin America's largest dialysis provider; entered new markets in Ecuador and Chile while deepening presence in Colombia; refinanced debt with a new $1.9 billion Term Loan B-2 and $3.5 billion credit facilities including a $2 billion Term Loan A-2 and $1.5 billion revolving facility in 2025; issued $1 billion in senior notes due 2033; and reported Q3 2025 revenues of $3.42 billion amid volume challenges from flu season, Hurricane Helene, and a cyber incident.
Company News
Did You Lose Money on DaVita Inc. Stock? The Law Offices of Howard G.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
DaVita Inc. to Participate in Upcoming Investor Conferences
Lost Money on DaVita Inc. Shares? The Law Offices of Frank R.
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y
What DaVita (DVA) Said on Its Q3 Earnings Call
DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript
DaVita HealthCare (DVA) Beats Q3 Earnings and Revenue Estimates
DaVita Q3 2026 Earnings Call Transcript
DaVita Inc. 3rd Quarter 2026 Results
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know
DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?
DaVita Inc. $DVA Position Lifted by CWA Asset Management Group LLC
DaVita Inc. Schedules 3rd Quarter 2026 Investor Conference Call
18,685 DaVita Inc. $DVA Shares Acquired by Counterpoint Mutual Funds LLC
DaVita Brings New Clinical Research to ASN Kidney Week 2026, Advancing Evidence for the Next Era of Kidney Care